Načítá se...
Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Genetic variations play an important role in the clinical presentation and progression of Alzheimer’s disease (AD), especially early-onset Alzheimer’s disease. Hundreds of mutations have been reported with the majority resulting from alterations in β-amyloid precursor protein (APP), presenilin 1 (PS...
Uloženo v:
| Vydáno v: | Clin Interv Aging |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808714/ https://ncbi.nlm.nih.gov/pubmed/29445268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S155145 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|